Oral beclomethasone dipropionate as an initial treatment of gastrointestinal acute graft-versus-host disease after reduced-intensity cord blood transplantation [3]

Bone Marrow Transplantation

Volumn 38, Issue 8, 2006, Pages 577-579

  Miura, Y ^a   Narimatsu, H ^a   Kami, M ^b   Kusumi, E ^a   Matsumura, T ^a   Yuji, K ^a   Wake, A ^a   Miyakoshi, S ^a   Taniguchi, S ^a  

^a TORANOMON HOSPITAL   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE DIPROPIONATE; CYCLOSPORIN; FLUDARABINE; FOSCARNET; GANCICLOVIR; MELPHALAN; METHYLPREDNISOLONE; PLACEBO; TACROLIMUS;

ACUTE GRAFT VERSUS HOST DISEASE; ADULT; AGED; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; ENTEROCOLITIS; FEMALE; GASTROINTESTINAL DISEASE; GRAFT VERSUS HOST REACTION; HEMATOLOGIC DISEASE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LETTER; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SOLID TUMOR; STEM CELL TRANSPLANTATION; UMBILICAL CORD BLOOD; WHOLE BODY RADIATION;

ACUTE DISEASE; ADMINISTRATION, ORAL; ADULT; AGED; BECLOMETHASONE; CORD BLOOD STEM CELL TRANSPLANTATION; FEASIBILITY STUDIES; FEMALE; GASTROINTESTINAL DISEASES; GRAFT VS HOST DISEASE; HUMANS; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 33749425982     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1705489     Document Type: Letter

References (10)

1. Martin LE, Tanner RJ, Clark TJ, Cochrane GM. Absorption and metabolism of orally administered beclomethasone dipropionate. Clin Pharmacol Ther 1974; 15: 267-275.
2. Tursi A, Giorgetti GM, Brandimarte G, Elisei W, Aiello F. Beclomethasone dipropionate for the treatment of mild-to-moderate Crohn's disease: An open-label, budesonide-controlled, randomized study. Med Sci Monit 2006; 12: PI29-PI32.
3. Rizzello F, Gionchetti P, Galeazzi R, Novelli G, Valpiani D, D'Arienzo A et al. Oral beclomethasone dipropionate in patients with mild to moderate ulcerative colitis: A dose-finding study. Adv Ther 2001; 18: 261-271.
4. Baehr PH, Levine DS, Bouvier ME, Hockenbery DM, Gooley TA, Stern JG et al. Oral beclomethasone dipropionate for treatment of human intestinal graft-versus-host disease. Transplantation 1995; 60: 1231-1238.
5. McDonald GB, Bouvier M, Hockenbery DM, Stern JM, Gooley T, Farrand A et al. Oral beclomethasone dipropionate for treatment of intestinal graft-versus-host disease: A randomized, controlled trial. Gastroenterology 1998; 115: 28-35.
6. Iyer RV, Hahn T, Roy HN, Battiwalla M, Cooper M, Anderson B et al. Long-term use of oral beclomethasone dipropionate for the treatment of gastrointestinal graft-versus-host disease. Biol Blood Marrow Transplant 2005; 11: 587-592.
7. Kishi Y, Kami M, Miyakoshi S, Kanda Y, Murashige N, Teshima T et al. Early immune reaction after reduced-intensity cord-blood transplantation for adult patients. Transplantation 2005; 80: 34-40.
8. Miyakoshi S, Yuji K, Kami M, Kusumi E, Kishi Y, Kobayashi K et al. Successful engraftment after reduced-intensity umbilical cord blood transplantation for adult patients with advanced hematological diseases. Clin Cancer Res 2004; 10: 3586-3592.
9. Martin PJ, Schoch G, Fisher L, Byers V, Anasetti C, Appelbaum FR et al. A retrospective analysis of therapy for acute graft-versus-host disease: initial treatment. Blood 1990; 76: 1464-1472.
10. Narimatsu H, Matsumura T, Kami M, Miyakoshi S, Kusumi E, Takagi S et al. Bloodstream infection after umbilical cord blood transplantation using reduced-intensity stem cell transplantation for adult patients. Biol Blood Marrow Transplant 2005; 11: 429-436.